At the IGTP TODAY
The GCAT team at IGTP has developed PolyGenie, a new open tool that enables researchers to explore and reuse genomic data more easily. Designed to support large-scale genetic association studies, the platform advances GCAT's commitment to FAIR data and Open Science. Its development and application to the GCAT cohort are described in NAR Genomics and Bioinformatics.
IGTP will coordinate INTERACT-NF, a new European COST Action that will bring together 68 researchers from 13 countries to advance research on neurofibromatosis and schwannomatosis. The network will foster collaboration between researchers, clinicians and patient organisations to address the main challenges associated with these rare diseases.
Roger Paredes (Germans Trias Hospital, IrsiCaixa and the Fight Infections Foundation) coordinates the international NAVIS study, launched by the WHO to advance knowledge of Andes hantavirus. The initiative also includes an advanced virology and immunology study coordinated by IrsiCaixa and IGTP Principal Investigators Julià Blanco and Nuria Izquierdo-Useros.
The DIVINE cohort brings together clinical data from 5,813 patients hospitalised with COVID-19 during the first four waves of the pandemic and makes it available to the scientific community through an open, accessible and reusable resource. Published in Scientific Data, this multicentre database has already contributed to several studies and aims to support further research into the clinical progression of COVID-19, associated risk factors and the development of predictive models.
A team from the IGTP, in collaboration with the Home Hospitalisation Service (HAD) of the Germans Trias i Pujol University Hospital and the technology company Doole Health, has evaluated the usability of an artificial intelligence-based voice assistant for the remote clinical monitoring of patients. The results show good acceptance among both healthcare professionals and patients, including individuals with limited access to or use of digital technologies.
_1780404906.jpeg)
The European project BT4ChildLC, led by IGTP, has advanced precision medicine for childhood liver cancer by combining large-scale biological data with innovative preclinical models to identify new biomarkers and therapeutic strategies. The results provide a strong foundation for future international studies and highlight the importance of collaboration in advancing research into rare paediatric cancers.
On the occasion of World Multiple Sclerosis Day, GCAT-IGTP, in collaboration with the Hospital del Mar Research Institute, has promoted a video exploring multiple sclerosis through the perspectives of clinical practice, biomedical research and personal experience. The video highlights current research into the link between multiple sclerosis and the Epstein-Barr virus, as well as the value of population cohorts such in advancing more preventive and personalised medicine.
CEEISCAT, a research group at IGTP, is developing Pan-Téstate, an online self-sampling program aimed at improving early screening for HIV and viral hepatitis among GBMSM and trans women in Spain. Using dried blood spot samples collected at home, the initiative seeks to reduce barriers to testing and improve access to early diagnosis and prevention.
The B-DLNM methodology enables the analysis of complex, time-dependent exposure-response relationships using a flexible Bayesian framework. The bdlnm package makes this approach accessible to researchers through a user-friendly implementation.
IGTP took part in the 2026 edition of MWC and 4YFN with professionals and spin-offs from the institute, showcasing projects in health innovation and strengthening its role in connecting biomedical research with companies, investors and institutions to advance technologies with potential clinical and societal impact.
